Protein Therapy for Cardiovascular Disease Treatment

A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biomedical Engineering and Biomaterials".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 82

Special Issue Editors


E-Mail Website
Guest Editor
Department of Surgery, University of Virginia, Charlottesville, VA 22903, USA
Interests: regenerative medicine; cardiovascular diseases; aging; cancer biology; diabetes

E-Mail Website
Guest Editor
Division of Surgical Sciences, Department of Surgery, University of Virginia, Charlottesville, VA 22903, USA
Interests: muscle physiology; ion channels; protein therapeutics; regenerative medicine

Special Issue Information

Dear Colleagues,

Myocardial infarction (MI) occurs due to the blockage of coronary arteries, leading to ischemia of the myocardium and inflammatory cell death. The dead cardiac tissue is replaced by fibrous scar tissue, causing a decline in myocardial contractile strength and impacting the functional capacity of the heart. While treatments such as stent placement, vascular bypass, and transplantation are beneficial, they have limitations. There is an urgent need to develop novel protein therapeutics to control inflammation and to improve the regenerative capacity of the heart in the setting of acute MI and chronic heart failure.

New approaches involving biologics, cell-based, or a combination of biologics and cell therapies are emerging as potential means for cardiovascular diseases. The development of an effective delivery system is crucial to ensure that therapeutic proteins reach the target tissues in the body. The exploration of various methods, including injections, implants, and other advanced drug and cell delivery technologies, is essential for this purpose.

Prof. Dr. Jianjie Ma
Dr. Ki Ho Park
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • myocardial infarction
  • heart failure
  • vein graft
  • intimal hyperplasia
  • aneurysm
  • stem cells
  • nanoparticle
  • transplantation
  • CRISPR
  • MyoAAV
  • tissue repair
  • inflammation

Published Papers

This special issue is now open for submission.
Back to TopTop